Skip to main content
. Author manuscript; available in PMC: 2012 Jun 29.
Published in final edited form as: J Appl Microbiol. 2010 Oct 21;110(1):229–238. doi: 10.1111/j.1365-2672.2010.04874.x

Figure 1.

Figure 1

Haemoglobin release from human red blood cells (panel a) after addition of CSA-13 to their phosphate-buffered saline (PBS) suspension without (▲) or with 1% (○) or 5% (□) of pluronic F-127. Antibacterial activity of CSA-13 against Pseudomonas aeruginosa Xen 5 (panel b) and Staphylococcus aureus A1 (panel c) in PBS (▲) or PBS containing 1% (○) or 5% (□) pluronic F-127. Error bars represent standard deviations from three measurements. *Significantly different from control sample.